FMR LLC and Abigail P. Johnson filed a Schedule 13G with the SEC on November 5, 2026, disclosing beneficial ownership of common stock in Thermo Fisher Scientific Inc. as of September 30, 2026.

Key Highlights

  • Aggregate beneficial ownership: FMR LLC and Abigail P. Johnson each report beneficial ownership of 22,261,362.05 shares of Thermo Fisher Scientific common stock.
  • Percent of class: The reported holdings represent 6.0% of the outstanding common stock, according to the filing.
  • Sole voting power (FMR LLC): FMR LLC reports sole voting power over 20,235,010.53 shares, with 0.00 shares subject to shared voting power.
  • Sole dispositive power: Both FMR LLC and Abigail P. Johnson each report sole dispositive power over 22,261,362.05 shares, with no shared dispositive power reported.
  • Event date: The filing is triggered by an event dated September 30, 2026.
  • Ordinary course certification: The filing certifies that the securities "were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer."

FMR LLC and Johnson Disclose September 30, 2026 Position in Thermo Fisher Scientific

According to the Schedule 13G filed November 5, 2026, FMR LLC, a Delaware-organized holding company located at 245 Summer Street, Boston, Massachusetts 02210, reported aggregate beneficial ownership of 22,261,362.05 shares of common stock (CUSIP 883556102) of Thermo Fisher Scientific Inc. (NYSE:TMO), headquartered at 168 Third Avenue, Waltham, MA 02451. The filing identifies FMR LLC as a parent holding company or control person under Rule 13d-1(b)(1)(ii)(G).

Abigail P. Johnson, a United States citizen, is separately listed as a reporting person in the same filing, also disclosing aggregate beneficial ownership of 22,261,362.05 shares, representing 6.0% of the class. Johnson is identified as an individual (type "IN") and reports sole dispositive power over the same share count, but reports 0.00 shares under sole or shared voting power, distinct from FMR LLC's reported sole voting power of 20,235,010.53 shares.

The filing notes that "one or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the common stock," but states that no single other person's interest exceeds five percent of the total outstanding common stock. The statement was signed by Stephanie J. Brown, acting under a power of attorney on behalf of both FMR LLC and Abigail P. Johnson. Subsidiary identification is provided in an attached Exhibit 99, as required under Item 7 of the Schedule 13G.

What Was Disclosed

FMR LLC and Abigail P. Johnson filed a Schedule 13G reporting a combined beneficial ownership position of 22,261,362.05 shares, equal to 6.0% of Thermo Fisher Scientific's common stock, as of September 30, 2026.